Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion

Ann Lab Med. 2016 May;36(3):287-9. doi: 10.3343/alm.2016.36.3.287.

Authors

Jihye Ha¹, June Won Cheong², Saeam Shin³, Seung Tae Lee⁴, Jong Rak Choi¹

Affiliations

¹ Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
² Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
³ Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. [email protected].
⁴ Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. [email protected].

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Base Sequence
Bone Marrow / pathology
Fusion Proteins, bcr-abl / genetics*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
Male
Middle Aged
Real-Time Polymerase Chain Reaction

Substances

BCR-ABL1 fusion protein, human
Fusion Proteins, bcr-abl